According to research reviewed by Gram, compounds from the rubber plant Ficus elastica lowered blood fats in rats fed a high-fat diet, with effects statistically comparable to the cholesterol drug simvastatin. Because the study used animals and computer models, these results do not yet prove the plant helps people lower cholesterol.
Researchers wanted to know whether natural compounds from the rubber plant (Ficus elastica) could help control high cholesterol and blood fats. In an early study, rats fed a high-fat diet received plant compounds that improved their blood fat levels, with results statistically comparable to the cholesterol drug simvastatin. One plant fraction also brought a marker of cell damage down to the level seen in healthy rats, and the aortas of treated rats showed signs of less early artery damage. Computer simulations suggested that two of the identified compounds might bind well to proteins involved in cholesterol control. According to research reviewed by Gram, these results are promising, but they come from animal and computer studies. Scientists have not yet tested these compounds in people, so they cannot be considered a treatment for humans at this time.
Key Statistics
A 2026 animal study published in Research in Pharmaceutical Sciences found that compounds from the rubber plant Ficus elastica improved blood fat levels in rats fed a high-fat diet, with effects statistically comparable to simvastatin.
In the same 2026 study, researchers tested eight plant fractions and identified four major chemical constituents, including phlorin, clausarinol, ginsenoyne C, and piptolinic acid A, though the identification was described as tentative.
A 2026 rat study reported that one plant fraction, subfraction 4, reduced a marker of cell damage called malondialdehyde to levels statistically indistinguishable from healthy control animals.
The Quick Take
- What they studied: Can natural compounds found in the rubber fig plant help lower blood fats like cholesterol and protect blood vessels from early damage?
- Who participated: The study used laboratory rats that were fed a high-fat diet to make their blood fats rise. The exact number of rats was not listed in the study summary. Some tests were also run in test tubes and on computers, without living participants.
- Key finding: Rats given the plant compounds showed better blood fat levels in a way that was similar to simvastatin, a common cholesterol medicine. One plant fraction also lowered a marker of cell damage to about the same level as healthy rats.
- What it means for you: This is an early step, not proof that the plant helps people. Do not use the rubber plant or any supplement made from it to replace prescribed cholesterol medicine. Talk with your doctor about proven ways to manage cholesterol, such as diet, exercise, and medication when needed.
The Research Details
The researchers worked in three steps. First, they separated the plant into eight smaller groups, called subfractions, and tested each one in a test tube to see which best blocked an enzyme the liver uses to make cholesterol. The strongest group, called subfraction 4, was then chosen for further testing.
Next, they fed rats a high-fat diet to raise their blood fats, then gave some rats different doses of the plant compound, some rats simvastatin, and some rats no treatment. They measured blood fats, a marker of cell damage called malondialdehyde, and looked at the rats’ aortas, the body’s largest artery, under a microscope.
Finally, they used a lab technique called mass spectrometry to identify the chemicals in the plant, then ran computer simulations to predict how well those chemicals might fit onto proteins involved in cholesterol control.
Testing in steps helps narrow down which parts of a plant might be useful before spending time and money on bigger studies. Using animals with diet-induced high blood fats allows scientists to see how a treatment affects the whole body, including blood vessels. Comparing results to a known medicine like simvastatin gives a useful reference point for how strong the effects are.
The study used several different methods and compared results to a standard medicine and to healthy animals, which adds confidence. However, the sample size was not clearly reported in the summary, the study was done in rats rather than people, and the chemical identities were described as tentative. The computer predictions are only suggestions and need lab confirmation. The full paper should be checked for details on group sizes and statistical methods.
What the Results Show
The main result was that the plant compounds improved every blood fat measure the researchers tracked in rats fed a high-fat diet. The improvements grew stronger as the dose increased, which is a sign that the effect may be real and linked to the amount given.
The researchers reported that these effects were statistically comparable to simvastatin, a widely used cholesterol-lowering medicine. This means the differences between the plant treatment and the medicine were not large enough to be considered meaningful in this experiment. Statistically comparable does not mean identical, and the rats were not people.
One plant fraction, subfraction 4, also lowered malondialdehyde, a marker of oxidative stress, which is a type of cell damage linked to heart disease. Its levels returned to a point that could not be distinguished from healthy control rats. This suggests the plant may help calm this type of cell damage.
Under the microscope, the aortas of treated rats appeared better preserved, with healthier inner lining and more organized elastic fibers. The inner layers of the artery wall were also thinner, which may mean less early plaque buildup.
The laboratory chemistry work identified four main compounds in the plant: phlorin, clausarinol, ginsenoyne C, and piptolinic acid A. These are the chemicals that may be responsible for the effects, but the identification was described as tentative, meaning it still needs confirmation with pure samples.
The computer simulations suggested that clausarinol may bind to PCSK9, a protein that affects how the liver removes bad cholesterol from the blood, and ginsenoyne C may bind to PPAR-alpha, a protein involved in fat metabolism. Predicted binding strength was higher than for simvastatin in these models. These predictions are useful for guiding future lab work but do not prove the compounds act this way in the body.
Many plants have been studied for cholesterol benefits, and some natural compounds have shown similar effects on the same liver enzyme that simvastatin targets. This study adds the rubber fig plant to that list. Other research on plant-based approaches has also used rat models and computer modeling before moving to human trials, so this study follows a familiar path. Its results fit with the general idea that plant chemicals may complement standard cholesterol care, but more evidence is needed before any firm conclusions can be drawn.
The biggest limitation is that the study was done in rats and in test tubes, and results in animals do not always match results in people. The study summary also did not report how many rats were used, which makes it harder to judge how reliable the results are. The chemical identities of the compounds were described as tentative. The computer predictions are estimates only. There is also no information in the summary about long-term safety, the right dose for people, or how the compounds would be absorbed and processed by the human body.
The Bottom Line
Based on this early research, there is no reason yet to change your cholesterol treatment because of this study. The findings are promising and worth following up, but the confidence level for human benefit is low at this stage. Anyone with high cholesterol should continue evidence-based care, including diet changes, physical activity, and prescribed medications when needed. Any future use of this plant should first be tested in human clinical trials.
Researchers studying natural medicines, drug developers, and people with high cholesterol who want to follow emerging research may find this study interesting. People taking statins or other cholesterol medicines should not stop or change their medication based on this study. Pregnant or nursing people, children, and people with liver or kidney disease should be especially careful with any plant supplement and should consult a doctor first.
Lab and animal findings like these usually take years to reach people. Human safety testing, dose studies, and clinical trials would typically come first, and these steps often take several years. Even if the compounds prove useful, it may be a long time before any product based on them is available. Nothing from this study should be expected to change anyone’s blood fat levels in the near term.
Frequently Asked Questions
Can the rubber plant lower cholesterol in people?
Not yet known. A 2026 study found that compounds from Ficus elastica improved blood fats in rats fed a high-fat diet, with effects comparable to simvastatin. Human clinical trials have not been reported, so the plant cannot be considered a proven cholesterol treatment for people.
How does the rubber fig plant compare to simvastatin?
In rat experiments, the plant compounds produced blood fat improvements that were statistically comparable to simvastatin, a widely used statin medicine. Computer simulations also suggested some compounds might bind strongly to cholesterol-related proteins. These findings are preliminary and do not show the plant is a replacement for prescribed medication.
What compounds in Ficus elastica might help with cholesterol?
Researchers identified four major compounds: phlorin, clausarinol, ginsenoyne C, and piptolinic acid A. The identification was described as tentative. Computer models suggested clausarinol and ginsenoyne C might bind to cholesterol-related proteins, but these predictions still need confirmation in laboratory and human studies.
Should I take rubber plant supplements to lower my cholesterol?
Current research does not support using rubber plant supplements for cholesterol. The study was done in rats and computer models, with no reported human safety or dosing data. Anyone with high cholesterol should follow guidance from their doctor, including diet, exercise, and any prescribed medication.
Want to Apply This Research?
- Track your total cholesterol, LDL, HDL, and triglycerides from your regular lab results, recording the date and test type each time. If you are working with a doctor on cholesterol, log any supplements you take, including the dose and start date, so you can review changes with your provider.
- Use the app to set a weekly goal for heart-healthy habits that have proven benefits, such as eating at least five servings of vegetables and fruit, adding fiber-rich foods like oats and beans, and walking 30 minutes on most days. Log these habits daily so you can see patterns over time.
- Schedule a blood lipid test with your doctor at least once or twice a year, or as often as they recommend. Keep a monthly log of your habits, medications, and any supplements. Review trends every three months and share the summary with your healthcare provider. Watch for any new research on this plant, but only change your routine after your doctor agrees.
This article summarizes an early study conducted in rats and computer simulations and has not been tested in people. It is for general education only and is not medical advice. Do not start, stop, or change any cholesterol medicine or supplement without talking to a licensed healthcare provider, especially if you take statins or have heart, liver, or kidney conditions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.